GIP acts as a physiological blood glucose stabilizer associated with stimulation of insulin and glucagon secretion during hyper- and hypoglycemia, respectively, in healthy subjects and in patients with T2D (10, 29). This evidence concerns the gene GCG and type 2 diabetes mellitus.